BioNTech ships 11,500 doses of COVID vaccine to China
Send a link to a friend
[December 22, 2022]
(Reuters) -BioNTech said on Thursday it had shipped 11,500 doses
of its COVID-19 vaccine to China to be administered initially to German
expatriates, marking the first foreign coronavirus vaccines to be sent
to the country.
BioNTech said the delivery, which landed in China on Wednesday,
contained both the original COVID-19 vaccine targeting the original
strain of the coronavirus, and its updated vaccine targeting the
BA.4/BA.5 subvariants of Omicron.
"The arrival of the vaccine doses on the Chinese Mainland is a great
milestone for us as joint partners with Fosun Pharma and
our efforts to address this pandemic, said Sean Marett, BioNTech's chief
business and commercial officer.
The vaccines are expected to be available in Beijing, Shanghai,
Guangzhou, Shenyang and Chengdu, BioNTech said.
The group is working with Shanghai Fosun Pharmaceutical to deliver the
shots to greater China.
The shipment comes as Beijing dismantles its strict "zero-COVID" regime
of lockdowns, which has led to a surge in cases. China has so far
insisted on using only domestically produced vaccines for its own
population. These are not based on the Western mRNA technology.
[to top of second column]
|
A vial labelled with the Pfizer-BioNTech
coronavirus disease (COVID-19) vaccine is seen in this illustration
picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration
The BioNTech vaccines will be sent
to German companies in China as well as embassy locations and talks
are underway with other European Union governments about getting
them to citizens of other nationalities, a source familiar with the
situation said on Wednesday.
China would need to approve expanding access beyond the about 20,000
German nationals, the source said.
A French health ministry official said on Thursday France had not
yet taken a decision how best to vaccinate expatriates in China but
that the government was following the situation carefully.
(Reporting by Manas Mishra in Bengaluru, additional reporting by
Elizabeth Pineau in Paris; Editing by Shounak Dasgupta, Shailesh
Kuber and Jane Merriman)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |